Neupath Health Inc. (NPTH) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, everyone, and welcome to NewPath Health's Q2 2026 earnings call. Today is August the 13th, 2026. Financial statements and MD&A have been filed and are available on the CDAR Plus website. Stephen Lemieux, Chief Executive Officer, and Jeff Zygouras, NewPath's Chief Financial Officer, will present the company's financial results and provide a business update, followed by a Q&A session. Investors are encouraged to submit their questions via the Q&A box, and we will address them at the end of the session. Please make your questions clear and succinct. Welcome, gentlemen, and please begin your presentation. Great. Thank you, Martin. Thank you everyone for joining us. We're just going to go through a brief presentation on the quarter and then we'll open the floor up to questions. So just a quick recap about NUPATH. So we are one of Canada's largest operators of community-based medical facilities, focusing on treating chronic and MSK pain. We have approximately 160 healthcare professionals in our network that see roughly 200,000 patients annually. And majority of our patients are referred to us from a network of over 5,000 referring physicians. We operate 12 facilities in Canada, mostly in Ontario and Alberta and we continue to have a high patient satisfaction rating. In our second quarter highlights, so to note here in our Q2 of 2025, we had a material one-time payment. It impacted revenue by 1.9 million and adjusted EBITDA by 0.6 million. We've revised the numbers you'll see in this presentation to reflect excluding that impact. So excluding that impact, our revenue grew 7% to 23.2 million, adjusted EBITDA grew 3% to 1.7%. We continue to be under levered, so we're at 0.4 times, which gives us a lot of capacity to work on some of the business development trans...